September Update and Circular to Shareholders

AI SummaryClose X

MedPal AI plc reported strong September 2026 trading, with New Health revenue exceeding £2.7 million, a 50% increase from August, and the group's annualised revenue run rate surpassing £38 million. Repeat orders and recurring business generated over £1 million in September, representing approximately one-third of the group's £3.2 million total revenue for the month, with the company dispensing 58,859 prescription items. The company is also seeking shareholder approval to renew authorities for issuing equity securities to support continued growth and working capital needs, with expanded GLP-1 capacity expected to open by the end of October.

Disclaimer*

UK 100

Latest directors dealings